The Application segment delineates how Cardiovascular Image Processing Software is deployed across clinical and research environments, directly shaping market size. Diagnostic imaging—including echocardiography, computed tomography (CT), magnetic resonance imaging (MRI), and nuclear imaging—captures the largest share, as hospitals and imaging centers require sophisticated algorithms for plaque quantification, ventricular function analysis, and flow visualization. Interventional procedures represent a growing niche, where real‑time image processing supports catheter‑based therapies, electrophysiology mapping, and structural heart interventions, driving incremental revenue through procedure‑specific licensing. Research and education accounts for a smaller yet strategic portion, supplying academic institutions and pharmaceutical firms with tools for simulation, algorithm development, and training modules. Each application contributes distinct revenue streams: diagnostic imaging fuels recurring subscription fees, interventional tools command premium per‑procedure pricing, and research licenses generate project‑based income. Collectively, these sub‑segments define the overall market footprint, and the phrase “Cardiovascular Image Processing Software segmentation” underscores their analytical separation.